Finance

Lists
Outlook: 73.3% bullish·0.0% bearish
Go to analysis
GEHC:NASDAQ
GE HealthCare Technologies Inc
$64.77
-1.48%
(-0.97) 1D
$65.09
+0.49% (+0.32)
After hours
Closed: Oct 6, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GEHC...
Open
$66.04
High
$66.55
Low
$64.67
Mkt. cap
28.61B
Avg. vol.
3.37M
Volume
3.55M
Dividend
0.25%
Quarterly dividend
$0.04
Ex-dividend date
Oct 23, 2026
P/E ratio
14.89
52-wk high
$89.77
52-wk low
$58.75
EPS
$4.35
Beta
0.85
Shares outstanding
451.69M
No. of employees
54K
Open
$66.04
High
$66.55
Low
$64.67
Mkt. cap
28.61B
Avg. vol.
3.37M
Volume
3.55M
Dividend
0.25%
Quarterly dividend
$0.04
Ex-dividend date
Oct 23, 2026
P/E ratio
14.89
52-wk high
$89.77
52-wk low
$58.75
EPS
$4.35
Beta
0.85
Shares outstanding
451.69M
No. of employees
54K
News stories
From web sources and news partners
Profile
GE Healthcare Technologies, Inc., stylized GE HealthCare, is an American health technology company based in Chicago, Illinois. It operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures contrast agents and radiopharmaceuticals. GE HealthCare's primary customers are hospitals and health networks. In 2023, the company received 42% of its revenue in the United States and 13% of its revenue from China, where the company faces increasing competition. GE HealthCare was originally the healthcare division of the American conglomerate General Electric, which spun it off in 2023 as an independent, publicly traded company. It operates in more than 100 countries, with GE HealthCare major regional operations in Buc, France; Helsinki, Finland; Kraków, Poland; Budapest, Hungary; Yizhuang, China; Hino & Tokyo, Japan, and Bangalore, India. Wikipedia
About GE HealthCare Technologies Inc
CEOPeter J Arduini
Employees54K
Founded1994
HeadquartersChicago, Illinois, United States
SectorMedical device
Websitegehealthcare.com
Analyst ratings
Based on 15 analysts giving stock ratings to GEHC in the past 3 months
Buy
Buy
10
Hold
5
Sell
0
12-month forecast
Based on 15 Wall Street analysts offering 12 month price targets for GEHC in the last 3 months.
Highest
Current $64.77
$93.00 (+43.58%)
Average
$79.73 (+23.10%)
Lowest
$70.00 (+8.07%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ryan Zimmerman
BTIG
Buy
Maintained
$79.00
+22%
10/05/2026
David Saxon
Needham
Buy
Reiterated
$93.00
+43.6%
10/05/2026
Joanne Wuensch
Citi
Hold
Maintained
$71.00
+9.6%
10/05/2026
Kendall Au
RBC Capital
Buy
Maintained
$80.00
+23.5%
10/01/2026
Vik Chopra
BMO Capital
Hold
Maintained
$71.00
+9.6%
09/13/2026
Travis Steed
Bank of America Securities
Hold
Maintained
$74.00
+14.3%
09/14/2026
Larry Biegelsen
Wells Fargo
Buy
Reiterated
$85.00
+31.2%
08/25/2026
Graham Doyle
UBS
Hold
Reiterated
$73.00
+12.7%
07/31/2026
Anthony Petrone
Mizuho Securities
Buy
Maintained
$85.00
+31.2%
07/31/2026
Robbie Marcus
J.P. Morgan
Hold
Reiterated
$70.00
+8.1%
07/30/2026
Rick Wise
Stifel Nicolaus
Buy
Maintained
$80.00
+23.5%
07/30/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
$84.00
+29.7%
07/30/2026
Suraj Kalia
Oppenheimer
Buy
Maintained
$85.00
+31.2%
07/30/2026
Matthew Taylor
Jefferies
Buy
Reiterated
$92.00
+42%
07/30/2026
Shagun Singh Chadha
RBC Capital
Buy
Reiterated
$80.00
+23.5%
07/29/2026
Jason Bednar
Piper Sandler
Buy
Reiterated
$74.00
+14.3%
07/24/2026
Unknown Analyst
BMO Capital
Hold
Initiated
$70.00
+8.1%
07/09/2026
David Roman
Goldman Sachs
Hold
Downgraded
-
-
04/30/2026
Matt Miksic
Barclays
Hold
Maintained
$78.00
+20.4%
04/30/2026
David Toung
Argus Research
Buy
Reiterated
$95.00
+46.7%
03/03/2026
Patrick Wood
Morgan Stanley
Hold
Maintained
$85.00
+31.2%
02/05/2026
Nico Chen
DBS
Buy
Maintained
$100.00
+54.4%
01/28/2026
Last report
Jul 29, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$1.13 / $1.04
+9.09%beat
Revenue / Est. (USD)
5.30B / 5.26B
+0.69%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
5.14B
5.70B
5.13B
5.30B
Cost of goods sold
3.15B
3.44B
3.15B
3.12B
Cost of revenue
3.15B
3.44B
3.15B
3.12B
Research and development expenses
292.00M
323.00M
345.00M
323.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
966.00M
1.04B
1.06B
1.06B
Operating expense
1.26B
1.36B
1.41B
1.39B
Total operating expenses
4.41B
4.80B
4.56B
4.50B
Operating income
731.00M
896.00M
569.00M
793.00M
Other non operating income
11.00M
4.00M
36.00M
7.00M
EBT including unusual items
643.00M
821.00M
505.00M
693.00M
EBT excluding unusual items
643.00M
821.00M
505.00M
693.00M
Income tax expense
179.00M
219.00M
94.00M
119.00M
Effective tax rate
27.84%
26.67%
18.61%
17.17%
Other operating expenses
-
-
-
-
Net income
446.00M
589.00M
389.00M
561.00M
Net profit margin
8.67%
10.34%
7.58%
10.59%
Earnings per share
1.07
1.44
0.99
1.13
Interest and investment income
12.00M
24.00M
-
7.00M
Interest expense
-128.00M
-6.00M
-115.00M
-133.00M
Net interest expenses
-116.00M
18.00M
-115.00M
-126.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
879.00M
1.04B
722.00M
953.00M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps